Your session is about to expire
← Back to Search
Brain Activity Monitoring for Prostate Cancer Post-Surgery
N/A
Recruiting
Led By Khurshid A Guru
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults who undergo robot-assisted radical prostatectomy (RARP)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is investigating whether there are certain brain waves that are associated with being able to control the bladder after a radical prostatectomy.
Who is the study for?
This trial is for adults with prostate cancer who are able to control their bladder before surgery and will undergo robot-assisted radical prostatectomy. They must understand the study's experimental nature and agree to it by signing a consent form. Those unable or unwilling to follow the study plan, or deemed unsuitable by the investigator, cannot participate.
What is being tested?
The trial studies brain activity (using EEG) and pelvic floor muscle activity (using EMG) in patients having robot-assisted surgery for prostate cancer. It aims to link specific brain waves with muscle control that affects bladder function post-surgery.
What are the potential side effects?
Since this trial involves monitoring techniques like EEG and EMG rather than drug interventions, side effects are minimal but may include discomfort from electrode placement or skin irritation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult who will have or has had a robotic surgery for prostate cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
EEG measures obtained during urination.
Identification of Areas of synchrony in EEG Patterns and associated Urodynamics (UDS) findings
Electroencephalography
Secondary study objectives
EEG and EMG biofeedback
Improvement of continence
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Supportive Care (brain and muscle monitoring, questionnaire)Experimental Treatment4 Interventions
Patients perform standard of care Kegel exercises while undergoing brain and muscle activity monitoring by UDS, EEG and EMG, respectively, before surgery, 6 weeks after surgery, and at 3, and 6 months after surgery. Patients complete questionnaires over 5-10 minutes about urinary function
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Electroencephalography
2013
N/A
~850
Electromyography
2018
N/A
~320
Find a Location
Who is running the clinical trial?
Roswell Park Cancer InstituteLead Sponsor
414 Previous Clinical Trials
33,622 Total Patients Enrolled
19 Trials studying Prostate Cancer
1,291 Patients Enrolled for Prostate Cancer
Khurshid A GuruPrincipal InvestigatorRoswell Park Cancer Institute
2 Previous Clinical Trials
106 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am an adult who will have or has had a robotic surgery for prostate cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive Care (brain and muscle monitoring, questionnaire)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.